Estrella Immunopharma (ESLA) Short Interest Ratio & Short Volume $2.21 +0.50 (+29.24%) (As of 07/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsOwnershipSEC FilingsShort InterestTrends Estrella Immunopharma Short Interest DataCurrent Short Interest19,100 sharesPrevious Short Interest17,600 sharesChange Vs. Previous Month+8.52%Dollar Volume Sold Short$28,650.00Short Interest Ratio1.1 Days to CoverLast Record DateJuly 15, 2024Outstanding Shares36,380,000 sharesFloat Size9,120,000 sharesShort Percent of Float0.21%Today's Trading Volume3,942,393 sharesAverage Trading Volume57,629 sharesToday's Volume Vs. Average6,841% Short Selling Estrella Immunopharma ? Sign up to receive the latest short interest report for Estrella Immunopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartESLA Short Interest Over TimeESLA Days to Cover Over TimeESLA Percentage of Float Shorted Over Time Ad Behind the MarketsJ.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal warns, "America's bonds are getting harder to sell."Click here to see why Wall Street is in PANIC mode >>> Estrella Immunopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/202419,100 shares $28,650.00 +8.5%0.2%1.1 $1.50 6/30/202417,600 shares $18,480.00 +60.0%0.2%1.2 $1.05 6/15/202411,000 shares $10,340.00 +0.9%0.1%0.8 $0.94 5/31/202410,900 shares $10,320.12 +18.5%0.1%0.5 $0.95 5/15/20249,200 shares $9,936.00 -18.6%0.1%0.3 $1.08 4/30/202411,300 shares $11,865.00 +145.7%0.1%0.4 $1.05 4/15/20244,600 shares $4,876.00 -41.8%0.1%0.2 $1.06 3/31/20247,900 shares $9,796.00 +61.2%0.1%0.2 $1.24 3/15/20244,900 shares $5,439.00 -88.1%0.1%0.1 $1.11 2/29/202441,100 shares $41,922.00 -28.0%0.5%1 $1.02 2/15/202457,100 shares $62,239.00 +117.9%0.7%1.2 $1.09 1/31/202426,200 shares $29,344.00 No Change0.3%0.5 $1.12 ESLA Short Interest - Frequently Asked Questions What is Estrella Immunopharma's current short interest? Short interest is the volume of Estrella Immunopharma shares that have been sold short but have not yet been closed out or covered. As of July 15th, traders have sold 19,100 shares of ESLA short. 0.21% of Estrella Immunopharma's shares are currently sold short. Learn More on Estrella Immunopharma's current short interest. What is a good short interest ratio for Estrella Immunopharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ESLA shares currently have a short interest ratio of 1.0. Learn More on Estrella Immunopharma's short interest ratio. What is a good short interest percentage for Estrella Immunopharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.21% of Estrella Immunopharma's floating shares are currently sold short. Is Estrella Immunopharma's short interest increasing or decreasing? Estrella Immunopharma saw a increase in short interest in the month of July. As of July 15th, there was short interest totaling 19,100 shares, an increase of 8.5% from the previous total of 17,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Estrella Immunopharma's float size? Estrella Immunopharma currently has issued a total of 36,380,000 shares. Some of Estrella Immunopharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Estrella Immunopharma currently has a public float of 9,120,000 shares. How does Estrella Immunopharma's short interest compare to its competitors? 0.21% of Estrella Immunopharma's shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Estrella Immunopharma: Outlook Therapeutics, Inc. (14.28%), Coherus BioSciences, Inc. (20.06%), Candel Therapeutics, Inc. (7.55%), Fennec Pharmaceuticals Inc (8.62%), Innate Pharma S.A. (0.09%), Acumen Pharmaceuticals, Inc. (3.74%), Adverum Biotechnologies, Inc. (9.37%), INmune Bio, Inc. (20.28%), Zura Bio Limited (5.41%), Kodiak Sciences Inc. (3.97%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks. What does it mean to sell short Estrella Immunopharma stock? Short selling ESLA is an investing strategy that aims to generate trading profit from Estrella Immunopharma as its price is falling. ESLA shares are trading up $0.50 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Estrella Immunopharma? A short squeeze for Estrella Immunopharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ESLA, which in turn drives the price of the stock up even further. How often is Estrella Immunopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ESLA, twice per month. The most recent reporting period available is July, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Outlook Therapeutics Short Interest Data Coherus BioSciences Short Interest Data Candel Therapeutics Short Interest Data Fennec Pharmaceuticals Short Interest Data Innate Pharma Short Interest Data Acumen Pharmaceuticals Short Interest Data Adverum Biotechnologies Short Interest Data Compugen Short Interest Data INmune Bio Short Interest Data Zura Bio Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ESLA) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredThe #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredDon't Pay a Dime for Marc Lichtenfeld's Top AI PicksUsually, you'd have to plunk down a hefty sum to get your hands on Marc Lichtenfeld's latest income research.....The Oxford Club | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Estrella Immunopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Estrella Immunopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.